In-silico approaches for identification of compounds inhibiting SARS-CoV-2 3CL protease
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0284301 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Md Zeyaullah und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Science, College of Applied Medical Sciences, Khamis Mushayt Campus, King Khalid University (KKU), Abha, Kingdom of Saudi…. Hauptthemen laut MEDLINE: Peptide Hydrolases, COVID-19. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research at King Khalid University.
Abstract (Originalsprache)
The world has witnessed of many pandemic waves of SARS-CoV-2. However, the incidence of SARS-CoV-2 infection has now declined but the novel variant and responsible cases has been observed globally. Most of the world population has received the vaccinations, but the immune response against COVID-19 is not long-lasting, which may cause new outbreaks. A highly efficient pharmaceutical molecule is desperately needed in these circumstances. In the present study, a potent natural compound that could inhibit the 3CL protease protein of SARS-CoV-2 was found with computationally intensive search. This research approach is based on physics-based principles and a machine-learning approach. Deep learning design was applied to the library of natural compounds to rank the potential candidates. This procedure screened 32,484 compounds, and the top five hits based on estimated pIC 50 were selected for molecular docking and modeling. This work identified two hit compounds, CMP4 and CMP2, which exhibited strong interaction with the 3CL protease using molecular docking and simulation. These two compounds demonstrated potential interaction with the catalytic residues His41 and Cys154 of the 3CL protease. Their calculated binding free energies to MMGBSA were compared to those of the native 3CL protease inhibitor. Using steered molecular dynamics, the dissociation strength of these complexes was sequentially determined. In conclusion, CMP4 demonstrated strong comparative performance with native inhibitors and was identified as a promising hit candidate. This compound can be applied in-vitro experiment for the validation of its inhibitory activity. Additionally, these methods can be used to identify new binding sites on the enzyme and to design new compounds that target these sites.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Basic Medical Science, College of Applied Medical Sciences, Khamis Mushayt Campus, King Khalid University (KKU), Abha, Kingdom of Saudi Arabia (KSA).
- Department of Chemical Engineering, Indian Institute of Technology Delhi, New Delhi, India.
- Department of Public Health, College of Applied Medical Sciences, Khamis Mushayt Campus, King Khalid University (KKU), Abha, Kingdom of Saudi Arabia (KSA).
- Department of Medical Laboratory Technology, College of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia.
- Department of Chemistry, Indian Institute of Technology Delhi, New Delhi, India.
- Department of Microbiology, All India Institute of Medical Sciences Delhi, New Delhi, India.
ORCID-Profile: Razi Ahmad, Wajihul Hasan Khan
Förderung
- Deanship of Scientific Research at King Khalid University
Zitieren
APA
Zeyaullah, M., Khan, N., Muzammil, K., AlShahrani, A. M., Khan, M. S., Alam, M. S., Ahmad, R., & Khan, W. H. (2023). In-silico approaches for identification of compounds inhibiting SARS-CoV-2 3CL protease. PLOS ONE. https://doi.org/10.1371/journal.pone.0284301
Vancouver
Zeyaullah M, Khan N, Muzammil K, AlShahrani AM, Khan MS, Alam MS, et al. In-silico approaches for identification of compounds inhibiting SARS-CoV-2 3CL protease. PLOS ONE. 2023. doi:10.1371/journal.pone.0284301
BibTeX
@article{Zeyaullah2023,
author = {Zeyaullah, Md and Khan, Nida and Muzammil, Khursheed and AlShahrani, Abdullah M and Khan, Mohammad Suhail and Alam, Md Shane and Ahmad, Razi and Khan, Wajihul Hasan},
title = {In-silico approaches for identification of compounds inhibiting SARS-CoV-2 3CL protease},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0284301}
}
EUVIMED